StockData

Niagen Bioscience vs Natural Alternatives International

NAGE and NAII side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How NAGE and NAII compare

Niagen Bioscience is the larger company, worth 7.4 times as much as Natural Alternatives International ($159M against $21.4M).

Natural Alternatives International grew revenue faster over the last twelve months (9.7% versus −1.9% for Niagen Bioscience).

Niagen Bioscience keeps more of each dollar of sales as profit, with a net margin of 8.4% compared with −14.5% at Natural Alternatives International.

Niagen Bioscience scores higher on the StockData Score (14 against 6 for Natural Alternatives International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricNAGENAII
Size and price
Market cap$159M$21.4M
Share price$2.01$0.970
Change, 1 year−71.2%−71.1%
Change, 5 years−59.1%−92.6%
Beta (5Y)1.080.01
Employees117219
StockData Score
Total score14 (better)6
Valuation score3 (better)1
Growth score11
Performance score4 (better)2
Health score6 (better)2
Dividend score00
Valuation
P/E16.8×–
P/S1.3×0.2× (better)
P/B1.9×0.4× (better)
EV/EBITDA18.8×–
FCF yield–−58.8%
Fair value$2.30–
Margin of safety12.6%–
Growth
Revenue growth (TTM)−1.9%9.7% (better)
Revenue growth, 5Y average16.9% (better)−4.4%
Net income growth (TTM)−49.9%–
EPS growth (TTM)−50.0%–
Profitability
Gross margin63.9% (better)6.3%
Operating margin3.9% (better)−13.2%
Net margin8.4% (better)−14.5%
FCF margin–−8.9%
Return on equity13.3% (better)−35.0%
Return on invested capital44.3% (better)−25.2%
Financial health
Debt / equity0.000.20 (better)
Current ratio5.93 (better)1.73
Altman Z-score3.87 (better)1.50
Piotroski F-score7 (better)2
Dividends and buybacks
Buyback yield3.4% (better)0.41%
Shareholder yield3.4% (better)0.41%
Ownership
Held by institutions40.4%10.5%
Held by insiders5.1%5.0%
Insider net buying, 12 months$0$26.8K (better)
Short interest, % of float5.8%0.03%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.